NUS — Stock Film
STOCK FILMSCENE 1/11NUS · $4.85
Stock Expert AI presents
NUS
Nu Skin Enterprises, Inc
~5 min film100% real numbersplain English
WHAT DOES THIS COMPANY DO?
Nu Skin Enterprises, Inc. What it actually does.

Develop and distribute skincare systems targeting anti-aging and skin treatment. Offer nutritional supplements focused on overall wellness and specific health benefits. Now — the numbers.

on the stock market since 1996
2,800 employees
$235.5M market value
WHERE DOES THE MONEY COME FROM?
92%Manufacturing
ManufacturingRhyz Other 8%Nu Skin 1%
92% of all revenue comes from a single line: Manufacturing.

That much dependence is a risk in itself: if this one line weakens, the whole company feels it directly.

Revenue last year:
$1.5B
The net profit left over:
$160.2M
Out of every $100 in sales, $11 stays as net profit.
THE SLICE THAT TURNS INTO PROFIT: 11%

This is an established company with proven profits.

THE SALES TREND
Sales have been shrinking.

An average decline of 14% a year over the last 4 years — the most striking risk in this picture. Red columns mark years that ended in a loss.

$2.7B
2021
2022
2023
2024
$1.5B
2025
What executives did with their own stock over the last 12 months:
20 buy12 sell

Executives buying with their own money is usually read as confidence in the company’s future.

INSIDE THE REPORT CARD

We compared this company with its own sector across five subjects.

A score of 50 means class average.

BUSINESS QUALITY
38
weak

Clearly below the class average.

FINANCIAL STRENGTH
43
weak

Clearly below the class average.

VALUATION
68
strong

Clearly above the class average — a step short of the very top.

GROWTH
40
weak

Clearly below the class average.

PRICE MOMENTUM
18
very weak

Clearly below the class average.

WORTH WATCHING

Price Momentum: The stock has lagged the market in recent months; investor interest is weak right now.

Business Quality: Profit power and business quality trail similar companies in the sector.

THE FIVE-YEAR JOURNEY
A long and steep decline.

An investor who bought at the very peak is down 91% today. The business is the same; what changed most is the price — and the expectations — the market pins on it.

1
THE BRIGHT SIDE · 1/2
Executives are buying their own stock

Over the last 12 months, company executives reported 20 buys and 12 sells. Management buying with its own money is usually read as a good sign.

2
THE BRIGHT SIDE · 2/2
Pays a steady dividend

It pays out $0.24 per share each year — regular cash for whoever holds the stock.

1
THE RISKS · 1/3
Sales are shrinking

Over the last 4 years, sales fell about 14% a year on average. Profit is holding up, but a shrinking business is a risk worth watching.

2
THE RISKS · 2/3
The stock has lost its spark

Buyers haven’t stepped back in yet; the price hasn’t found its footing. Report-card grade: 18/100. For a turnaround signal, the stock first needs to close the gap with the market.

3
THE RISKS · 3/3
The business trails its class

Measured against its sector, the quality of the business sits below the class average. Report-card grade: 38/100.

FINALE · THE GRADE
C
48 / 100 · MoonshotScore

On our five-subject report card, NUS sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”

The takeaway: NUS does earn real profits — but on our report card it still sits behind its class. The real debate isn’t the quality of the business — it’s what that quality should cost.

The total grade weighs these five subjects against the sector — it isn’t a simple average of the five.

What would you like to do next?
Open the stock page →
This was a film — not investment advice.
Data: FMP & company filings
Sep 11, 2026 · stockexpertai.com · Stock Film